Advertisement



More in Pharmacy

Numerous Humira biosimilars are on the market after AbbVie's 20-year exclusive on the rheumatoid arthritis biologic, but they aren't fostering much competition, KFF Health News reported Sept. 19. 

Tom Vadaketh, executive vice president and CFO of pharmaceutical company Bausch Health Cos., has resigned from his role and will be leaving the company effective Oct. 13.

The shortages of Novo Nordisk's Ozempic and Wegovy, a Type 2 diabetes and weight loss drug, respectively, could continue for years, Forbes reported Sept. 16. 

Since late August, six medications have fallen into short supply, including one cancer therapy.

Advertisement
Advertisement
Advertisement